Cat.#: ACPP-1724
| Despition | FGF13 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 95.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1591 | Mouse VCAM1 Protein (AC1591) | 2 µg | inquiry |
| ACPP-1213 | CACNB2 Blocking Peptide (AC1213) | 250 µg | inquiry |
| ACPP-1656 | Human MAPT Protein (AC1656) | 2 µg | inquiry |
| ACPP-1817 | Human NT 4 Protein (AC1817) | 20 µg | inquiry |
| ACPP-1338 | Dopamine Receptor D1 Blocking Peptide (AC1338) | 250 µg | inquiry |
| ACPP-1653 | Human CRYM Protein (AC1653) | 2 µg | inquiry |
| ACPP-1730 | Human S100A8 Protein, His (AC1730) | 2 µg | inquiry |
| ACPP-1182 | Recombinant Cynomolgus macaque Midkine Protein (Fc Tag) (AC1182) | 10 µg | inquiry |
| ACPP-1134 | Recombinant Mouse ROR1 Protein (6×His Tag) (AC1134) | 50 µg | inquiry |
| ACPP-1110 | Recombinant Human ROR1 Protein (6×His Tag) (AC1110) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.